Keyword: Körmend
Egis announces further investments at its site in Körmend
Over the next few years, Egis Pharmaceuticals PLC will invest EUR 21.1 million to increase its capacity at its Körmend site. To finance these developments, Egis will use its own capital and a government subsidy of EUR 3.4 million – announced Csaba Poroszlai, CEO of Egis. In total, the company will devote more than EUR 50 million to the development of the Körmend site of Egis since 2019.
New Unit Inaugurated at Egis’s Körmend Plant
Egis and our consortia partners have won 2,332 billion HUF direct grant in the framework of the innovation tender GINOP-2.2.1-15-2016-00023 for the realisation of the above-mentioned project.
Channels
Egis is present in 62 countries with its products.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the 2021/2022 business year, the company’s product portfolio consisted of 642 products
In the 2021/2022 business year, we spent more than EUR 45 million on research and development
Healthcare and sharing knowledge are in the heart of our CSR activities
Our highlighted past and future events you shouldn't miss
Your browser is out of date. Please, use an updated version!